The results showed that the percentage of CD3+CD8-IFNγ+ T cells was increased in each of the tumor-bearing mice groups compared with the healthy mice, whereas the percentage of CD3+CD8+IFNγ+ T cells only increased in mice immunized five times with the vaccine. This evidence concerns the gene IFNG and neoplasm.